Baird Financial Group, Inc. Staar Surgical CO Transaction History

Baird Financial Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$122.75 - $162.68 $1.32 Million - $1.75 Million	-10,727 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$105.76 - $154.96 $346,258 - $507,339	3,274 Added 43.93%	10,727 $1.64 Million
Q1 2021 May 13, 2021	SELL	$78.5 - $126.48 $111,941 - $180,360	-1,426 Reduced 16.06%	7,453 $786,000
Q4 2020 Feb 11, 2021	BUY	$55.93 - $82.78 $76,512 - $113,243	1,368 Added 18.21%	8,879 $703,000
Q3 2020 Nov 12, 2020	BUY	$45.65 - $61.81 $62,540 - $84,679	1,370 Added 22.31%	7,511 $425,000
Q2 2020 Oct 22, 2020	BUY	$29.15 - $61.54 $179,010 - $377,917	6,141 New	6,141 $378,000

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.35B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.